(ABIRATERONE ACETATE 250 MG TAB)
ONCOLOGY(ABIRATERONE ACETATE 250 MG TAB)
ONCOLOGYABIRABAY 250 is typically prescribed for the following conditions:
1. Prostate cancer: It is used in combination with other medications to treat metastatic castration-resistant prostate cancer, a form of prostate cancer that no longer responds to hormone therapy.
ABIRABAY 250 contains the active ingredient Abiraterone Acetate. Abiraterone Acetate is used in the treatment of prostate cancer, particularly in cases that are resistant to other treatments. It works by inhibiting an enzyme called CYP17, which is involved in the production of androgens (male hormones) in the body, including testosterone. By blocking this enzyme, Abiraterone Acetate reduces the production of androgens, which can slow down the growth of prostate cancer cells.
ABIRABAY 250 is typically prescribed for the following conditions:
1. Prostate cancer: It is used in combination with other medications to treat metastatic castration-resistant prostate cancer, a form of prostate cancer that no longer responds to hormone therapy.
The dosage of ABIRABAY 250 will vary depending on the specific condition being treated, the patient's overall health, and the doctor's recommendations.
It is typically taken orally, usually once daily, on an empty stomach, at least one hour before or two hours after a meal.
Follow your healthcare provider's instructions regarding the dosage and duration of treatment.
ABIRABAY 250 may cause side effects in some individuals. Common side effects may include:
1. Fatigue
2. Joint swelling or pain
3. High blood pressure
4. Fluid retention
5. Irregular heartbeat
6. Changes in liver function tests
7. Diarrhea
8. Hot flashes
ABIRABAY 250 should not be used in certain situations, including:
1. Hypersensitivity or allergy to Abiraterone Acetate or any other components of the medication.
2. Women, especially those who are pregnant or breastfeeding, should not use this medication.